Industry News
Excerpt from the Press Release: EAST WINDSOR, N.J., Aug. 20, 2020 (GLOBE NEWSWIRE) — ForDoz Pharma has entered into an agreement with Lupin, to market and distribute 2 complex injectable products in advanced development stage at ForDoz, in US and its territories. The products are in the Oncology and Anti-infective therapeutic areas which when approved,…
Read More
Excerpt from the Press Release: Kaiser Permanente has joined a Phase 3 clinical trial to test a coronavirus vaccine candidate currently in production by Pfizer and BioNTech, and will seek to enroll 1,400 adults aged 18-85 in California and Oregon to join in the study, a press release from the medical organization states. The aim…
Read More
Excerpt from the Press Release: SAN DIEGO–(BUSINESS WIRE)–Quidel Corporation (NASDAQ: QDEL) (“Quidel”),a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has received Health Canada authorization to market and sell the Lyra® Direct SARS-CoV-2 Assay in Canada. (IO315563, COVID-19 Medical Device Authorization for Importation or Sale; 07/20/2020)…
Read More
Excerpt from the Article: PHILADELPHIA, Aug. 13, 2020 /PRNewswire/ — When the COVID-19 pandemic began earlier this year, doctors and researchers at Children’s Hospital of Philadelphia (CHOP) rapidly pivoted to focus on defeating the novel virus. Across the hospital, members of the CHOP team – from infectious disease researchers to population health experts – mobilized…
Read More
Excerpt from the Article: Though Philadelphia ranked second in a recent list of best cities for STEM diversity, but there’s still plenty of work to do to ensure underrepresented groups have access to the industry that so often spells prosperity for its workers. We’ve seen a number of efforts start up in the past few…
Read More
Excerpt from the Press Release: SAN DIEGO, Aug. 14, 2020 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today that in response to Adamis’ Pre-Investigational New Drug (IND) filing with the U.S. Food and Drug Administration (FDA), the FDA has provided detailed comments regarding the prospective use of Tempol in a randomized placebo…
Read More
Excerpt from the Press Release: OTTAWA, Ontario & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Variation Biotechnologies Inc., an Ottawa-based wholly-owned Canadian subsidiary of VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that it has been awarded up to a CAD$56 million contribution from the Strategic Innovation Fund of…
Read More
Excerpt from the Press Release: SAN DIEGO, Aug. 6, 2020 /PRNewswire/ — Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients with cancer, and Aegea Biotechnologies, Inc., an innovative private life science company with an extensive portfolio of issued patents…
Read More Excerpt from the Press Release: SOUTH SAN FRANCISCO, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (“BBB”) for treatment of neurodegenerative diseases, today announced that DNL151 has been selected to progress into late stage studies…
Read More
Excerpt from the Article: It was purely by chance that at the very moment Ala Stanford walked into a revival service at a Philly church last summer, a man fainted and was suddenly unable to move or speak. Frantic and afraid, the man’s wife, a friend of Stanford’s, asked the board-certified surgeon to ride in…
Read More